Melatonin can cause daytime sleepiness in older adults, while prescription sedatives such as benzodiazepines and Z-drugs can increase fall and cognitive risks. However, dementia studies have not directly measured the added fall risk of taking melatonin and a prescription sedative together, so no reliable combined-risk number exists. Using both deserves a medication review, especially after a new prescription, dose change, fall, or increase in daytime sleepiness. "Natural" does not mean melatonin is risk-free.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What does the evidence show?
- Why can daytime sleepiness become a problem?
- Which sedatives raise the clearest fall concerns?
- What about Lewy body dementia?
- What should caregivers review?
What does the evidence show?
A 2020 Cochrane review found no dementia randomized trials of benzodiazepines or Z-drug hypnotics. It therefore could not quantify their benefits or risks for dementia-related sleep problems, either alone or with melatonin. Melatonin's benefit also appears modest and uncertain.
Cochrane found low-certainty evidence that doses up to 10 mg produced little or no major sleep improvement over eight to 10 weeks in Alzheimer's disease. A 2025 meta-analysis of 10 trials involving 516 older adults with cognitive impairment or dementia found an average 12.4-minute increase in total sleep time. Results varied substantially among studies, and the authors called for larger trials.
Why can daytime sleepiness become a problem?
Melatonin may remain active longer in older adults and cause daytime drowsiness, according to the NIH National Center for Complementary and Integrative Health. U.S. melatonin supplements also receive less stringent FDA oversight than medicines, so caregivers should not treat every product as interchangeable. Prescription hypnotics can produce similar concerns.
FDA labeling for zolpidem reports that, among trial participants aged 60 or older, drowsiness occurred in 5% of users compared with 2% taking placebo. Most reported falls involved people aged 70 or older. Daytime sleepiness after combining products does not prove a drug interaction. It does show that the person's full regimen, including timing and doses, needs review.
Which sedatives raise the clearest fall concerns?
The 2023 American Geriatrics Society Beers Criteria recommend avoiding benzodiazepines and Z-drugs in older adults with dementia or cognitive impairment because of adverse central-nervous-system effects. The criteria also warn that benzodiazepines increase falls and fractures. Timing may matter when a benzodiazepine is started.
In a case-crossover study of 594 nursing-home residents who fell, beginning a benzodiazepine was associated with 2.65-fold higher odds of falling within 24 hours. The residents averaged 87.5 years old, and most had moderate cognitive impairment. That result does not establish the risk from melatonin, every sedative, or every care setting. It does support closer observation when a benzodiazepine is newly introduced.
What about Lewy body dementia?
In Lewy body dementia, NIH guidance says melatonin may help REM sleep behavior disorder either alone or with clonazepam. That specific use does not establish that the combination is broadly safe for insomnia.
Clonazepam can cause dizziness, unsteadiness, and thinking problems. NIH also cautions that treatments for sleep problems may worsen daytime sleepiness, making the balance between nighttime benefit and daytime function especially important. A caregiver should tell the treating clinician about changes in alertness, balance, or thinking rather than judging the treatment only by hours slept.
What should caregivers review?
Bring one complete list to the clinician or pharmacist. Include prescription medicines, over-the-counter products, vitamins, and supplements rather than listing melatonin separately.
- Record each product's name, dose, and time taken.
- Note when sleepiness, dizziness, unsteadiness, thinking changes, or falls began.
- Highlight any sedative that was recently started or changed.
- Ask what benefit each sleep treatment is expected to provide.
- Discuss whether exercise, daytime activity, and avoiding long daytime naps are appropriate.
